tiprankstipranks
LakeShore Biopharma (LSB)
NASDAQ:LSB
US Market

LakeShore Biopharma (LSB) Financial Statements

Compare
85 Followers

LakeShore Biopharma Financial Overview

LakeShore Biopharma's market cap is currently $43.01M. The company's EPS TTM is $; its P/E ratio is ―; LakeShore Biopharma is scheduled to report earnings on January 27, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Mar 23Mar 22Mar 21
Income Statement
Total Revenue¥ 573.42M¥ 687.20M¥ 502.95M¥ 257.02M
Gross Profit¥ 455.73M¥ 533.84M¥ 385.88M¥ 197.36M
Operating Income¥ -445.83M¥ -139.38M¥ -549.18K¥ -125.85M
EBITDA¥ -368.66M¥ -76.80M¥ -67.20M¥ -116.78M
Net Income¥ -433.46M¥ -145.48M¥ -545.73K¥ -191.83M
Balance Sheet
Cash & Short-Term Investments¥ 246.35M¥ 370.11M¥ 885.20K¥ 390.46M
Total Assets¥ 1.51B¥ 1.72B¥ 201.03M¥ 91.37K
Total Debt¥ 424.46M¥ 498.63M¥ 380.59M¥ 5.01K
Net Debt¥ 178.11M¥ 128.52M¥ 379.70M¥ -390.45M
Total Liabilities¥ 927.82M¥ 991.30M¥ 20.35M¥ 70.01K
Stockholders' Equity¥ 585.21M¥ 728.45M¥ 180.68M¥ 21.36K
Cash Flow
Free Cash Flow¥ -339.48M¥ -239.52M¥ -299.55M¥ -351.49M
Operating Cash Flow¥ -295.23M¥ -182.47M¥ -613.23K¥ -246.61M
Investing Cash Flow¥ -44.25M¥ -56.98M¥ -200.00M¥ -104.24M
Financing Cash Flow¥ 205.26M¥ 317.45M¥ 201.50M¥ 739.26M
Currency in CNY

LakeShore Biopharma Earnings and Revenue History

LakeShore Biopharma Debt to Assets

LakeShore Biopharma Cash Flow

LakeShore Biopharma Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis